Copyright
©The Author(s) 2025.
World J Gastroenterol. Dec 7, 2025; 31(45): 111643
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.111643
Published online Dec 7, 2025. doi: 10.3748/wjg.v31.i45.111643
Figure 1 The multifactorial risk landscape contributing to metabolic dysfunction-associated steatotic liver disease in Egypt.
MASLD: Metabolic dysfunction-associated steatotic liver disease; DM: Diabetes mellitus.
Figure 2 Suggested public health framework for metabolic dysfunction-associated steatotic liver disease prevention in Egypt.
MASLD: Metabolic dysfunction-associated steatotic liver disease.
- Citation: Abdelhamed W, Amin M, Waked I, El-Kassas M. Metabolic dysfunction-associated steatotic liver disease in Egypt: Epidemiology, risk factors and management challenges. World J Gastroenterol 2025; 31(45): 111643
- URL: https://www.wjgnet.com/1007-9327/full/v31/i45/111643.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i45.111643
